Scientific Publications

Search by Keyword(s)
Found 3 results

Filters: Author is Granter, SR  [Clear All Filters]

Search Results

  • Showing 1-3 of 3 Results
2016
Ipilimumab for Patients with Relapse after Allogeneic Transplantation.Davids, MS, Kim HT, Bachireddy P., Costello C., Liguori R., Savell A., Lukez AP, Avigan D., Chen YB, McSweeney P., LeBoeuf NR, Rooney MS, Bowden M., Zhou CW, Granter SR, Hornick JL, Rodig SJ, Hirakawa M., Severgnini M., Hodi FS, et al. The New England journal of medicine, 2016/07/14, Volume 375, Issue 2, p.143-53, (2016) Read More / View Supplemental Materials
Abstract
2013
PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.Vazquez, F., Lim JH, Chim H., Bhalla K., Girnun G., Pierce K., Clish CB, Granter SR, Widlund HR, Spiegelman BM, and Puigserver P. Cancer cell, 2013/03/18, Volume 23, Issue 3, p.287-301, (2013) Read More / View Supplemental Materials
Abstract
2005
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.Garraway, LA, Widlund HR, Rubin MA, Getz G., Berger AJ, Ramaswamy S., Beroukhim R., Milner DA, Granter SR, Du J., Lee C., Wagner SN, Li C., Golub T. R., Rimm DL, Meyerson ML, Fisher DE, and Sellers WR Nature, 2005/07/07, Volume 436, Issue 7047, p.117-22, (2005) Read More / View Supplemental Materials
Abstract
  • Showing 1-3 of 3 Results